Kathryn Penkus Corzo
CIK: 0001884123
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MRKR
Marker Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Corzo Kathryn Penkus
Corzo Kathryn Penkus (SEC CIK 0001884123) files insider reports with the SEC as Director of Marker Therapeutics, Inc. (MRKR).
Signal8 holds 2 ownership filings by Corzo Kathryn Penkus (1 Form 3, 1 Form 4), filed on Nov 4, 2025. Those filings report 1 transaction, the latest on Oct 31, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Corzo Kathryn Penkus's filings is in HOUSTON, TX.
Recent filings by Corzo Kathryn Penkus
- Oct 31, 2025: Grant or award of MRKR derivative securities (Form 4, code A).
Other insiders filing for Marker Therapeutics, Inc. (MRKR)
- Knobil Katharine, Director
- Eansor Norman David, Director
- ELMS STEVE, Director
- Vera Juan, President and CEO
- New Enterprise Associates 16, L.P., 10% Owner